ResMed, Inc. (RMD)
231.36
-8.74
(-3.64%)
USD |
NYSE |
Sep 01, 16:00
229.51
-1.85
(-0.80%)
Pre-Market: 08:02
ResMed Cash from Investing (Quarterly) : -383.65M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -383.65M |
| March 31, 2026 | -58.03M |
| December 31, 2025 | -50.94M |
| September 30, 2025 | -52.58M |
| June 30, 2025 | -133.71M |
| March 31, 2025 | -31.79M |
| December 31, 2024 | -36.69M |
| September 30, 2024 | 2.146M |
| June 30, 2024 | -46.51M |
| March 31, 2024 | -33.15M |
| December 31, 2023 | -41.14M |
| September 30, 2023 | -148.98M |
| June 30, 2023 | -46.52M |
| March 31, 2023 | -28.10M |
| December 31, 2022 | -1.026B |
| September 30, 2022 | -58.81M |
| June 30, 2022 | -55.24M |
| March 31, 2022 | -49.50M |
| December 31, 2021 | -83.31M |
| September 30, 2021 | -41.87M |
| June 30, 2021 | -48.07M |
| March 31, 2021 | -58.62M |
| December 31, 2020 | -29.66M |
| September 30, 2020 | -22.11M |
| June 30, 2020 | -3.407M |
| Date | Value |
|---|---|
| March 31, 2020 | -99.61M |
| December 31, 2019 | -43.62M |
| September 30, 2019 | -33.22M |
| June 30, 2019 | -43.89M |
| March 31, 2019 | -225.41M |
| December 31, 2018 | -658.22M |
| September 30, 2018 | -148.19M |
| June 30, 2018 | -38.53M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -28.26M |
| September 30, 2017 | -15.42M |
| June 30, 2017 | -31.28M |
| March 31, 2017 | -17.92M |
| December 31, 2016 | -19.52M |
| September 30, 2016 | -13.17M |
| June 30, 2016 | -818.16M |
| March 31, 2016 | -83.73M |
| December 31, 2015 | -161.11M |
| September 30, 2015 | -62.75M |
| June 30, 2015 | -23.48M |
| March 31, 2015 | -19.00M |
| December 31, 2014 | -59.00M |
| September 30, 2014 | -41.60M |
| June 30, 2014 | -22.84M |
| March 31, 2014 | -23.20M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Koninklijke Philips NV | -23.11M |
| Accuray, Inc. | -1.353M |
| Micron Solutions, Inc. | -- |
| Medtronic Plc | -1.619B |
| Orthofix Medical, Inc. | -12.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 454.63M |
| Cash from Financing (Quarterly) | -263.16M |
| Free Cash Flow | 1.629B |
| Free Cash Flow Per Share (Quarterly) | 2.741 |
| Free Cash Flow to Equity (Quarterly) | 414.63M |
| Free Cash Flow to Firm (Quarterly) | 397.38M |
| Free Cash Flow Yield | 4.82% |